Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126909952 | 12690995 | 2 | F | 20160920 | 20160826 | 20160926 | EXP | PHHY2016MX116988 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160926 | MD | MX | MX |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126909952 | 12690995 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 4.6 MG, (PATCH 5 CM2) | 22083 | 4.6 | MG | TRANS-THERAPEUTIC-SYSTEM | |||||||
| 126909952 | 12690995 | 2 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 9.5 MG, QD (PATCH 10 CM 2) | 22083 | 9.5 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | ||||||
| 126909952 | 12690995 | 3 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | U | 0 | ||||||||||
| 126909952 | 12690995 | 4 | C | MICARDIS | TELMISARTAN | 1 | Unknown | U | 0 | ||||||||||
| 126909952 | 12690995 | 5 | C | MELOX | MELOXICAM | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126909952 | 12690995 | 1 | Vein disorder |
| 126909952 | 12690995 | 3 | Product used for unknown indication |
| 126909952 | 12690995 | 4 | Product used for unknown indication |
| 126909952 | 12690995 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126909952 | 12690995 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126909952 | 12690995 | Arthropathy | |
| 126909952 | 12690995 | Balance disorder | |
| 126909952 | 12690995 | Dry mouth | |
| 126909952 | 12690995 | Dysphemia | |
| 126909952 | 12690995 | Eye injury | |
| 126909952 | 12690995 | Fall | |
| 126909952 | 12690995 | Gait disturbance | |
| 126909952 | 12690995 | Head injury | |
| 126909952 | 12690995 | Headache | |
| 126909952 | 12690995 | Nasal injury | |
| 126909952 | 12690995 | Peripheral swelling | |
| 126909952 | 12690995 | Product use issue | |
| 126909952 | 12690995 | Thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |